Role of PTPN22 in type 1 diabetes and other autoimmune diseases

Seminars in Immunology

Volumn 18, Issue 4, 2006, Pages 207-213

  Bottini, Nunzio ^a   Vang, Torkel ^b   Cucca, Francesco ^c,d   Mustelin, Tomas ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Autoimmunity; Diabetes; LYP; PTPN22; SNP; TID

Indexed keywords

LYMPHOID TYROSINE PHOSPHATASE; PHOSPHATASE; PROTEIN PTPN22; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOCHEMISTRY; CHROMOSOME 1P; CORRELATION ANALYSIS; DIABETOGENESIS; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC PREDISPOSITION; GRAVES DISEASE; HUMAN; IMMUNOGENETICS; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; NONHUMAN; POPULATION RESEARCH; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VITILIGO;

ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33745169029     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.03.008     Document Type: Review

References (56)

1. Gottlieb P.A., and Eisenbarth G.S. In: TheoFlopoulos A., and Bona C.A. (Eds). The molecular pathology of autoimmune diseases. 2nd ed. (2002), Taylor & Francis, New York, NY 588
2. Hirschhorn J.N. Genetic epidemiology of type 1 diabetes. Pediatr Diabetes 4 (2003) 87-100
3. Maier L.M., and Wicker L.S. Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 17 (2005) 601-608
4. Roep B.O. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46 (2003) 305-321
5. Kane L.P., Lin J., and Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol 12 (2000) 242-249
6. Nel A.E. T-cell activation through the antigen receptor. Part 1. Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 109 (2002) 758-770
7. Nel A.E., and Slaughter N. T-cell activation through the antigen receptor. Part 2. Role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy. J Allergy Clin Immunol 109 (2002) 901-915
8. Buchs A.E., and Rapoport M.J. T cell signaling and autoimmune diabetes. J Pediatr Endocrinol Metab 13 (2000) 1549-1554
9. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178 (1993) 87-99
10. Rapoport M.J., Lazarus A.H., Jaramillo A., Speck E., and Delovitch T.L. Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med 177 (1993) 1221-1226
11. Salojin K., Zhang J., Cameron M., Gill B., Arreaza G., Ochi A., et al. Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-zeta-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice. J Exp Med 186 (1997) 887-897
12. De Maria R., Todaro M., Stassi G., Di Blasi F., Giordano M., Galluzzo A., et al. Defective T cell receptor/CD3 complex signaling in human type 1 diabetes. Eur J Immunol 24 (1994) 999-1002
13. Nervi S., Atlan-Gepner C., Fossat C., and Vialettes B. Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways. J Autoimmun 13 (1999) 247-255
14. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
15. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36 (2004) 337-338
16. Smyth D., Cooper J.D., Collins J.E., Heward J.M., Franklyn J.A., Howson J.M.M., et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 (2004) 3020-3023
17. Ladner M.B., Bottini N., Valdes A.M., and Noble J.A. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 66 (2005) 60-64
18. Qu H., Tessier M.C., Hudson T.J., and Polychronakos C. Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study. J Med Genet 42 (2005) 266-270
19. Zheng W., and She J.X. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 54 (2005) 906-908
20. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 (2004) 330-337
21. van Oene M., Wintle R.F., Liu X., Yazdanpanah M., Gu X., Newman B., et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 52 (2005) 1993-1998
22. Hinks A., Barton A., John S., Bruce I., Hawkins C., Griffiths C.E., et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52 (2005) 1694-1699
23. Simkins H.M., Merriman M.E., Highton J., Chapman P.T., O'Donnell J.L., Jones P.B., et al. Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum 52 (2005) 2222-2225
24. Lee A.T., Li W., Liew A., Bombardier C., Weisman M., Massarotti E.M., et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 6 (2005) 129-133
25. Orozco G., Sanchez E., Gonzalez-Gay M.A., Lopez-Nevot M.A., Torres B., Caliz R., et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52 (2005) 219-224
26. Gregersen P.K., and Batliwalla F. PTPN22 and rheumatoid arthritis: gratifying replication. Arthritis Rheum 52 (2005) 1952-1955
27. Viken M.K., Amundsen S.S., Kvien T.K., Boberg K.M., Gilboe I.M., Lilleby V., et al. Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6 (2005) 271-273
28. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E.H., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75 (2004) 504-507
29. Wu H., Cantor R.M., Graham D.S., Lingren C.M., Farwell L., Jager P.L., et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 52 (2005) 2396-2402
30. Reddy M.V., Johansson M., Sturfelt G., Jonsen A., Gunnarsson I., Svenungsson E., et al. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun 6 (2005) 658-662
31. Velaga M.R., Wilson V., Jennings C.E., Owen C.J., Herington S., Donaldson P.T., et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89 (2004) 5862-5865
32. Skorka A., Bednarczuk T., Bar-Andziak E., Nauman J., and Ploski R. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 62 (2005) 679-682
33. Canton I., Akhtar S., Gavalas N.G., Gawkrodger D.J., Blomhoff A., Watson P.F., et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 6 (2005) 584-587
34. Rueda B., Nunez C., Orozco G., Lopez-Nevot Ma, de La Concha E.G., Martin J., and Urcelay E. C1858T functional variant of PTPN22 gene is not associated with celiac disease genetic predisposition. Hum Immunol 66 (2005) 848-852
35. Begovich A.B., Caillier S.J., Alexander H.C., Penko J.M., Hauser S.L., Barcellos L.F., et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 76 (2005) 184-187
36. Carlton V.E., Hu X., Chokkalingam A.P., Schrodi S.J., Brandon R., Alexander H.C., et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 77 (2005) 567-581
37. Huffmeier U., Steffens M., Burkhardt H., Lascorz J., Schurmeier-Horst F., Stander M., et al. Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet 43 (2006) 517-522
38. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., et al. Type 1 diabetes genetics consortium. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1435 multiplex families. Diabetes 54 (2005) 2995-3001
39. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77 (2005) 1044-1060
40. Cohen S., Dadi H., Shaoul E., Sharfe N., and Roifman C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase. Lyp Blood 93 (1999) 2013-2024
41. Matthews R.J., Bowne D.B., Flores E., and Thomas M.L. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 12 (1992) 2396-2405
42. Cloutier J.F., and Veillette A. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J 15 (1996) 4909-4918
43. Gregorieff A., Cloutier J.F., and Veillette A. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(Csk). J Biol Chem 273 (1998) 13217-13222
44. Nada S., Okada M., MacAuley A., Cooper J.A., and Nakagawa H. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 351 (1991) 69-72
45. lck at Tyr-505 and down-regulates its catalytic activity. EMBO J 11 (1992) 2919-2924
46. Chow L.M.L., Fournel M., Davidson D., and Veillette A. Negative regulation of T-cell receptor signalling by the tyrosine kinase p50csk. Nature 365 (1993) 156-160
47. Gjörloff-Wingren A., Saxena M., Williams S., Hammi D., and Mustelin T. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol 29 (1999) 3845-3854
48. Cloutier J.F., and Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189 (1999) 111-121
49. Ghose R., Shekhtman A., Goger M.J., Ji H., and Cowburn D. A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nat Struct Biol 8 (2001) 998-1004
50. Hill R.J., Zozulya S., Lu Y.L., Ward K., Gishizky M., and Jallal B. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 30 (2002) 237-244
51. Wu J., Katrekar K., Honigberg L.A., Smith A.M., Conn M.T., Tang J., et al. Identification of substrates of human protein tyrosine phosphatase PTPN22. J Biol Chem 281 (2006) 11002-11010
52. Davidson D., Bakinowski M., Thomas M.L., Horejsi V., and Veillette A. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 23 (2003) 2017-2028
53. Xu S., Huo J., Tan J.E., and Lam K.P. Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development. Mol Cell Biol 25 (2005) 8486-8495
54. Hasegawa K., Martin F., Huang G., Tumas D., Diehl L., and Chan A.C. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303 (2004) 685-689
55. Vang T., Congia M., Macis M.D., Musumeci L., Orru V., Zavattari P., et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37 (2005) 1317-1319
56. Burkhardt H., Huffmeier U., Spriewald B., Bohm B., Rau R., Kallert S., et al. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. Arthritis Rheum 54 (2006) 82-89